Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 4

1.

Targeting low molecular weight cyclin E (LMW-E) in breast cancer.

Nanos-Webb A, Jabbour NA, Multani AS, Wingate H, Oumata N, Galons H, Joseph B, Meijer L, Hunt KK, Keyomarsi K.

Breast Cancer Res Treat. 2012 Apr;132(2):575-88. doi: 10.1007/s10549-011-1638-4. Epub 2011 Jun 22.

PMID:
21695458
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Cyclin E and its low molecular weight forms in human cancer and as targets for cancer therapy.

Akli S, Keyomarsi K.

Cancer Biol Ther. 2003 Jul-Aug;2(4 Suppl 1):S38-47. Review.

PMID:
14508079
[PubMed - indexed for MEDLINE]
Free Article
3.

Deregulation of cyclin E meets dysfunction in p53: closing the escape hatch on breast cancer.

Barton MC, Akli S, Keyomarsi K.

J Cell Physiol. 2006 Dec;209(3):686-94. Review.

PMID:
17001684
[PubMed - indexed for MEDLINE]
4.

E- and A-type cyclins as markers for cancer diagnosis and prognosis.

Yasmeen A, Berdel WE, Serve H, Müller-Tidow C.

Expert Rev Mol Diagn. 2003 Sep;3(5):617-33. Review.

PMID:
14510182
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk